Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-02 · accession 0001787306-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-02 | ARQT | Burnett Patrick | See Remarks | S - Sale | $3.54 | -1,325 | 57.0K | -2% | -$4,690 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 1,325 | $3.54 | 57,032 | D | — | — | (F1) The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |